Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

4. Disposition of Latin American Operations (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenues	$ 16,658,000	$ 12,825,000
Product [Member]
Revenues	15,663,000	11,957,000
Service [Member]
Revenues	995,000	868,000
Latin America [Member] \| Product [Member] \| Supply Agreement [Member]
Revenues	3,007,000	$ 1,299,000
Latin America [Member] \| Service [Member] \| Technical Assistance [Member]
Revenues	208,000
Latin America [Member] \| Service [Member] \| Interest Income [Member]
Revenues	$ 189,000